Stanford University

Total Awards: 
Approved funds: 
Major Facility Name: 
Lorry I. Lokey Stem Cell Research Building
Institution type: 
Not for profit

Awards to the Institution

Tools and Technologies II: Irving Weissman Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,869,487
Training Grant I-1: Michael Longaker Stanford CIRM Training Program $3,733,707
Basic Biology III: Joanna Wysocka Enhancer-mediated gene regulation during early human embryonic development $1,425,600
Disease Team Research I: Alfred Lane iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa $11,709,574
Early Translational III: Renee Reijo Pera Autologous iPSC Therapy for Urinary Incontinence $5,279,607
Basic Biology I: Helen Blau Molecular Mechanisms of Reprogramming towards Pluripotency $1,414,841
Basic Biology II: Steven Artandi Self-renewal and senescence in iPS cells derived from patients with a stem cell disease $1,430,908
New Faculty I: Anne Brunet Molecular mechanisms involved in adult neural stem cell maintenance $2,348,520
Tools and Technologies II: Brian Rutt Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,930,608
Disease Team Therapy Development - Research: Joseph Wu Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $19,999,899
Basic Biology IV: Roel Nusse Asymmetric stem cell division oriented by a local self-renewing signal $1,195,811
Transplantation Immunology: Christopher Contag Engineering Embryonic Stem Cell Allografts for Operational Tolerance $1,447,956
Transplantation Immunology: Robert Negrin Regulatory T cell induced tolerance to ESC transplantation $1,427,980
Basic Biology III: Sean Wu Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells $1,425,600
Research Training II: Renee Reijo Pera CIRM Training Program $7,974,291
Transplantation Immunology: Kenneth Weinberg “Engineered immune tolerance by Stem Cell-derived thymic regeneration” $1,415,836
New Faculty II: Ching-Pin Chang VEGF signaling in adventitial stem cells in vascular physiology and disease $3,330,931
Early Translational III: Helen Blau Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,920
Basic Biology II: Garry Nolan Kinase signaling analysis of iPS cell reprogramming and differentiation $1,447,956
Basic Biology II: Aaron Hsueh Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation $1,432,197
Early Translational I: Michael Longaker Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,263,086
Basic Biology IV: Howard Chang Long noncoding RNAs for pluripotency and cell fate commitment $1,386,627
Basic Biology IV: Ben Barres Phenotyping Human Astrocytes in Health and Disease $1,385,517
Basic Biology IV: Gerald Crabtree Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch $1,392,426
Basic Biology IV: Anne Brunet Energy metabolism and aging pathways in human stem cell reprogramming and differentiation $1,414,044
Early Translational II: Michele Calos Stem Cell Therapy for Duchenne Muscular Dystrophy $2,325,933
Basic Biology IV: Michael Cleary Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells $1,244,455
Basic Biology IV: Alexander Dunn Role of mechanical signaling in stem cell self-renewal and differentiation $1,064,224
Basic Biology IV: Michelle Monje Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain $1,264,248
Comprehensive Grant: Julie Baker Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cell $2,628,635
Comprehensive Grant: Theo Palmer Immunology of neural stem cell fate and function $2,501,125
Comprehensive Grant: Christopher Zarins Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells $2,618,704
Comprehensive Grant: Renee Reijo Pera Human oocyte development for genetic, pharmacological and reprogramming applications $2,469,104
Comprehensive Grant: Irving Weissman Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells $2,636,900
Comprehensive Grant: Stefan Heller Generation of inner ear sensory cells from human ES cells toward a cure for deafness $2,469,373
Comprehensive Grant: Roel Nusse Guiding the developmental program of human embryonic stem cells by isolated Wnt factors $2,354,820
New Faculty I: Howard Chang Noncoding RNAs in Cell Fate Determination $3,203,926
New Faculty I: Karl Deisseroth Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $3,154,719
New Faculty I: Joanna Wysocka Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,374,020
SEED Grant: Krishna Shenoy Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium $634,287
Tools and Technologies II: Ricardo Dolmetsch Development of small molecule screens for autism using patient-derived iPS cells $1,884,808
Early Translational IV: Michele Calos Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
SEED Grant: Calvin Kuo Differentiation of Human Embryonic Stem Cells to Intestinal Fates $578,943
Tools and Technologies II: Sarah Heilshorn Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels $1,415,981
Disease Team Therapy Development - Research: Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $20,000,000
Disease Team Therapy Development III: Irving Weissman Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $12,726,396
SEED Grant: John Cooke EC regeneration in cerebrovascular ischemia: role of NO $658,125
Research Leadership 12: Hiromitsu Nakauchi Generation of functional cells and organs from iPSCs $6,152,065
Basic Biology I: Susan McConnell Identification and characterization of human ES-derived DA neuronal subtypes $1,407,076
SEED Grant: Aaron Hsueh Patient-specific cells with nuclear transfer $656,074
Basic Biology V: Xinnan Wang Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
Basic Biology I: Julien Sage The retinoblastoma (RB) gene family in cellular reprogramming $1,436,185
SEED Grant: Thomas Wandless Reprogramming Differentiated Human Cells to a Pluripotent State $647,681
Tools and Technologies II: Marius Wernig Cellular tools to study brain diseases affecting synaptic transmission $1,906,494
Basic Biology V: Helen Blau Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
SEED Grant: Kenneth Weinberg Embryonic stem cell-derived thymic epithelial cells $658,057
Shared Labs: Renee Reijo Pera Center for Human Embryonic Stem Cell Research and Education $5,873,191
Basic Biology III: Michael Clarke USP16 controls stem cell number: implications for Down Syndrome $1,425,600
Basic Biology V: Marius Wernig Mechanisms of human induced neuronal cell reprogramming $1,178,370
SEED Grant: Joseph Wu In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity $658,123
Tools and Technologies I: Helen Blau Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells $949,608
Basic Biology III: Renee Reijo Pera Correlated time-lapse imaging and single cell molecular analysis of human embryo development $1,425,600
Basic Biology V: Gary Steinberg Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
SEED Grant: Joanna Wysocka Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency $658,126
Major Facilities: John Hennessy Stanford SIM1 Building $43,578,000
Disease Team Planning: Thomas Rando Stem Cell Therapy for Muscular Dystrophy $52,650
SEED Grant: Phillip Yang In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction $658,125
Disease Team Planning: Robert Robbins {REDACTED} Cardiovascular Regenerative Team $55,000
SEED Grant: Susan McConnell Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease $633,170
Transplantation Immunology: Judith Shizuru Purified allogeneic hematopoietic stem cells as a platform for tolerance induction $1,403,557
Disease Team Research I: Gary Steinberg Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke $20,000,000
SEED Grant: Mark Kay Novel vectors for gene transfer into human ES cells $640,642
Disease Team Therapy Planning I: Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $109,676
Disease Team Research I: Irving Weissman Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells $19,999,996
SEED Grant: Julien Sage Functions of RB family proteins in human embryonic stem cells $520,777
Disease Team Therapy Planning I: Albert Wong Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Creativity Awards: Paul Utz [REDACTED] Program: Stem Cell & Developmental Biology Research Internships $288,750
New Cell Lines: Julie Baker Derivation of hESC Lines with Disease Lesions $1,424,412
Disease Team Therapy Planning I: Robert Robbins Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $108,895
New Faculty Physician Scientist: Alan Cheng Enhancing hair cell regeneration in mouse and human inner ear $3,266,595
New Cell Lines: Michele Calos Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses $1,406,875
New Faculty Physician Scientist: Michelle Monje White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” $2,975,536
New Cell Lines: Michael Longaker Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts $1,424,412
Early Translational III: Joseph Wu Heart Repair with Human Tissue Engineered Myocardium $4,766,231
Tissue Collection for Disease Modeling: Joachim Hallmayer Induced pluripotent stem cells from children with autism spectrum disorders $530,265
New Cell Lines: Renee Reijo Pera Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype $1,410,042
Tools and Technologies II: Michele Calos Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,619,627
Tissue Collection for Disease Modeling: Joseph Wu Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases $1,435,371
Icon for xls export

© 2013 California Institute for Regenerative Medicine